You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
As AI agents increasingly assist with biomedical and clinical data analysis, we need formal epistemic guardrails against small-sample survival analysis overclaims.
Proposed Rules for clinical.survival_analysis:
Event Count Boundary: If total uncensored events in any stratum $E < 10$, hazard ratio p-values must be clamped to FRAGILE maturity.
Proportional Hazards Assumption: Schoenfeld residual test failure ($p < 0.05$) must block single-hazard ratio reporting and require time-varying coefficient models.
Causal Blocking: Observational EHR survival curves must strictly block causal language (drug X improved survival$\rightarrow$drug X was associated with longer overall survival).
Please share your thoughts on these proposed invariants before we formalize them into the BioNexus registry.
reacted with thumbs up emoji reacted with thumbs down emoji reacted with laugh emoji reacted with hooray emoji reacted with confused emoji reacted with heart emoji reacted with rocket emoji reacted with eyes emoji
Uh oh!
There was an error while loading. Please reload this page.
Motivation
As AI agents increasingly assist with biomedical and clinical data analysis, we need formal epistemic guardrails against small-sample survival analysis overclaims.
Proposed Rules for
clinical.survival_analysis:FRAGILEmaturity.drug X improved survivaldrug X was associated with longer overall survival).Please share your thoughts on these proposed invariants before we formalize them into the BioNexus registry.
All reactions